Form 4: Reisz Edwin C. reports acquisition/exercise transactions in AVAH

Rhea-AI Filing Summary

Reisz Edwin C. reported acquisition or exercise transactions in a Form 4 filing for AVAH. The filing lists transactions totaling 287,457 shares. Following the reported transactions, holdings were 1,609,100 shares.

Insider Trade Summary

Net Buyer: 287,457 shares

Net Buy 3 txns

Insider Reisz Edwin C.

Role Chief Administrative Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.01 per share	50,304	$0.00	$0.00
Grant/Award	Common Stock, par value $0.01 per share	187,500	$0.00	$0.00
Grant/Award	Common Stock, par value $0.01 per share	49,653	$0.00	$0.00

Holdings After Transaction: Common Stock, par value $0.01 per share — 1,609,100 shares (Direct)

Footnotes (4)

1. F1. Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's 2022 long-term incentive awards.
2. F2. Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's 2023 long-term incentive awards.
3. F3. Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.
4. F4. Includes 529 shares acquired under the Registrant's Employee Stock Purchase Plan (the "ESPP") in December 2025

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/17/2026 - 05:30 PM Learn about SEC filing dates

FAQ

What insider transactions did AVAH executive Edwin C. Reisz report?

Edwin C. Reisz reported equity awards, not open-market trades. He acquired 50,304 and 187,500 Aveanna shares from vested performance-based restricted stock units and 49,653 shares from a new stock-settled restricted stock unit grant, all at a reported price of $0 per share.

Were the AVAH shares acquired by Edwin C. Reisz performance-based?

Yes, most reported shares were performance-based awards. Reisz earned 50,304 shares from 2022 performance-based restricted stock units and 187,500 shares from 2023 performance-based restricted stock units, reflecting vesting of long-term incentive awards rather than cash purchases in the market.

What is the vesting schedule for the new AVAH restricted stock units?

The new restricted stock unit grant has three-year cliff vesting. Reisz received 49,653 stock-settled restricted stock units that vest only after three years, meaning the entire award vests at once at the end of that period rather than gradually over time.

How many Aveanna (AVAH) shares does Edwin C. Reisz now directly own?

Reisz directly beneficially owns 1,609,100 Aveanna shares. This total reflects his holdings after the February 14, 2026 awards and includes 529 shares previously acquired through Aveanna’s Employee Stock Purchase Plan in December 2025 as part of his ongoing ownership.

Did Edwin C. Reisz pay cash to acquire the reported AVAH shares?

No cash purchase price was reported for these awards. All three transactions list a price of $0 per share, indicating they were grants or vesting of restricted stock units provided under Aveanna’s long-term incentive and stock compensation programs rather than open-market buys.

What role does Edwin C. Reisz hold at Aveanna Healthcare (AVAH)?

Edwin C. Reisz serves as Chief Administrative Officer of Aveanna. The Form 4 identifies him as an officer, not a director or 10% owner, and the reported stock awards reflect compensation tied to his executive role at the company.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reisz Edwin C.

(Last) (First) (Middle)

C/O AVEANNA HEALTHCARE HOLDINGS INC.

400 INTERSTATE NORTH PARKWAY SE

(Street)

ATLANTA GA 30339

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aveanna Healthcare Holdings, Inc. [ AVAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Administrative Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/14/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	02/14/2026		A		50,304(1)	A	$0	1,371,947(4)	D
Common Stock, par value $0.01 per share	02/14/2026		A		187,500(2)	A	$0	1,559,447	D
Common Stock, par value $0.01 per share	02/14/2026		A		49,653(3)	A	$0	1,609,100	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's 2022 long-term incentive awards.

2. Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's 2023 long-term incentive awards.

3. Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.

4. Includes 529 shares acquired under the Registrant's Employee Stock Purchase Plan (the "ESPP") in December 2025

	/s/ Jonathan Beckler, Attorney-in-Fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.